Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study.

Keywords : ["pathogenetic factor fan", "cause rhinoorbitocerebral mucormycosis", "observational study", "flame"]
Author : Fist_Author_Year_PM
115

Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.

Keywords : ["biphasic insulin aspart novomix", "switch exist insulin therapy", "initiate insulin therapy", "routine care safety", "improve observational study", "type diabetes", "patient", "effectiveness"]
Author : Fist_Author_Year_PM
121

Five-year LDL-cholesterol trend and its predictors among type 2 diabetes patients in an upper-middle-income country: a retrospective open cohort study.

Keywords : ["predictor among type diabetes patient", "retrospective open cohort study", "fiveyear ldlcholesterol trend", "uppermiddleincome country"]
Author : Fist_Author_Year_PM
127

Dietary intake in the diabetes prevention program cohort: baseline and 1-year post randomization.

Keywords : ["diabetes prevention program cohort baseline", "post randomization", "dietary intake"]
Author : Fist_Author_Year_PM
124

Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes.

Keywords : ["rosiglitazone plus metformin", "large observational study", "clinical practice result", "well tolerate", "type diabetes", "people", "effective"]
Author : Fist_Author_Year_PM
119

Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.

Keywords : ["clinical practice followup datum", "predictive european cohort", "type diabetes patient", "insulin detemir", "type", "safety", "efficacy"]
Author : Fist_Author_Year_PM
139

The IMPROVE study--a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts.

Keywords : ["improve studya multinational observational study", "type diabetes baseline characteristic", "eight national cohort"]
Author : Fist_Author_Year_PM
125

Switching from NPH insulin to once-daily insulin detemir in basal-bolus-treated patients with diabetes mellitus: data from the European cohort of the PREDICTIVE study.

Keywords : ["diabetes mellitus datum", "oncedaily insulin detemir", "nph insulin", "predictive study", "european cohort", "basalbolustreate patient", "switch"]
Author : Fist_Author_Year_PM
129

Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study.

Keywords : ["type diabetes subgroup analysis", "biphasic insulin aspart novomix", "human premix insulin", "improve observational study", "switch", "safety", "patient", "effectiveness"]
Author : Fist_Author_Year_PM
117

Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational study.

Keywords : ["biphasic insulin aspart biasp novomix", "improve observational study", "improve glycaemic control", "basal insulin", "subgroup analysis", "patient treat", "intensification"]
Author : Fist_Author_Year_PM
125